Showing results (2161-2170 of 3,833) with videos related to

Sort By:
Pageof 384
The Japanese Journal of Antibiotics|January 1, 1988
[Screening for antagonistic agents to the lethal toxicity of neocarzinostatin. II. Effects of various drugs in inhibiting the toxicity of neocarzinostatin in vivo]M Ouchi, K Toriyama, T Matsumoto, et al.
The Japanese Journal of Antibiotics|August 23, 2016
[New therapeutic strategies for pulmonary infection: the potency of immune activation by macrolides and Toll-like receptor agonist]Shigeki Nakamura, Koichi Izumikawa, Katsunori Yanagihara, et al.
The Japanese Journal of Antibiotics|September 1, 1986
[A clinical bacteriological efficacy study on a fosfomycin otic solution]K Deguchi, N Yokota, S Tanaka, et al.
The Japanese Journal of Antibiotics|February 1, 1976
[Distribution and changes of antibiotic susceptibility of genus Haemophilus (author's transl)]N Kosakai, T Oguri
The Japanese Journal of Antibiotics|July 9, 1999
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs]M Inoue, S Kubo, A Saito, et al.
The Japanese Journal of Antibiotics|July 9, 1999
[A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-negative bacilli]M Kuroyama, E Okamoto, K Yago
The Japanese Journal of Antibiotics|September 11, 1999
[Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections. Part III]R Ishihara, Y Suzuki, C Nishinari, et al.
The Japanese Journal of Antibiotics|October 6, 2000
[Antipseudomonal activity of carbapenem antibiotics]M Sunagawa, K Kanazawa, H Nouda
The Japanese Journal of Antibiotics|April 30, 1999
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution]Y Kumamoto, T Tsukamoto, T Hirose, et al.
The Japanese Journal of Antibiotics|April 30, 1999
[The in vitro properties of a new hydroxypyridone antimycotic rilopirox, with special reference to its anti-Candida activity]I Harada, K Mitsui, K Uchida, et al.
Pageof 384